Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study-Reference-Cited by-同舟云学术

Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study

Published:2020-08 Issue: Volume:158 Page:104950
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Viecca Maurizio,Radovanovic Dejan,Forleo Giovanni Battista,Santus Pierachille

Funder

“Fondazione Un Cuore per Milano”

Publisher

Elsevier BV

Subject

Pharmacology

Reference28 articles.

1. WHO Novel Coronavirus (2019-nCoV) SITUATION REPORT - 107;World Health Organization,2020

2. Management of COVID-19 respiratory distress;Marini;JAMA,2020

3. Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis;Panigada;J Thromb Haemost,2020

4. Critically ill COVID‐19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability;Tan;Am J Hemat,2020

5. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Tang;J Thromb Haemost,2020

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble platelet selectin and platelets in COVID-19: a multifaceted connection;Annals of Medicine & Surgery;2024-06-20

2. Current landscape of long COVID clinical trials;International Immunopharmacology;2024-05

3. Long COVID-19 and the potential use of palmitoylethanolamide;Linking Neuroscience and Behavior in COVID-19;2024

4. Effectiveness of competency-based training on Nurses’ performance regarding oxygen administration safety for children with respiratory disorders;International Journal of Africa Nursing Sciences;2024

5. Effects of Aspirin on Clinical Outcomes of COVID-19: A Meta-Analysis;Advances in Clinical Medicine;2024